Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Dapafyzin-M 5/1000 Tablet ER

Prescription Icon
Prescription Required

Marketer

Care Formulation Labs Pvt Ltd

Salt Composition

Dapagliflozin (5mg) + Metformin (1000mg)

Overview Dapafyzin-M 5/1000 Tablet ER

Dapafyzin-M 5/1000 Extended-Release tablets combine two medications to manage type 2 diabetes. This treatment helps regulate elevated blood glucose, minimizing the risk of serious diabetic complications and potentially preventing cardiovascular issues. Dapafyzin-M 5/1000 ER can be taken with food; consistent daily dosing aids adherence. Your physician will determine the appropriate dosage. Discontinuing treatment without medical consultation may lead to uncontrolled blood sugar, increasing the risk of severe complications such as renal impairment and vision loss. This medication is one component of a comprehensive diabetes management plan, which should include dietary adjustments, regular physical activity, and weight management as directed by your doctor. Common side effects include pharyngitis, nasal stuffiness, rhinorrhea, cephalalgia, nausea, emesis, and diarrhea. Adequate hydration is crucial to prevent dehydration. Genital candidiasis may occur in some patients; good hygiene practices can help mitigate this risk. Prior to initiating treatment, disclose any kidney or liver dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice before use. Limit alcohol consumption as it may exacerbate side effects. Regular blood glucose monitoring is essential while taking this medication.

Primary Ingredients of Dapafyzin-M 5/1000 Tablet ER

No text was provided to rewrite.

Uses of Dapafyzin-M 5/1000 Tablet ER

Managing type 2 diabetes

Major Benefits of Dapafyzin-M 5/1000 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dapafyzin-M 5/1000 Tablet ER whole; do not crush, chew, or divide it. Administer this extended-release tablet with a meal.

Common Side effects of Dapafyzin-M 5/1000 Tablet ER:

  • Nausea
  • Vomiting
  • Diarrhea
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Polyuria
  • Flatulence
  • Skin rash
  • Taste change
  • Difficulty in urination
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness
  • Back pain
  • Increased hematocrit
  • Decreased creatinine clearance
  • Dyslipidemia

How to use Dapafyzin-M 5/1000 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Dapafyzin-M 5/1000 Extended-Release Tablet with a meal.

How Dapafyzin-M 5/1000 Tablet ER works:

Dapagliflozin and Metformin, combined as Dapafyzin-M 5/1000 Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual-action approach leads to superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Dapafyzin-M 5/1000 Tablet ER and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Dapafyzin-M 5/1000 tablet might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Dapafyzin-M 5/1000 tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Dapafyzin-M 5/1000 Tablet ER cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Dapafyzin-M 5/1000 Tablet ER cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Dapafyzin-M 5/1000 Tablet ER :

Should you forget a Dapafyzin-M 5/1000 Tablet ER dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dapafyzin-M 5/1000 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Dapafyzin-M 5/1000 Tablet...
240
MRP 278
13% off